Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$23.91 - $31.3 $884,670 - $1.16 Million
37,000 Added 211.43%
54,500 $1.39 Million
Q2 2024

Aug 13, 2024

BUY
$23.0 - $31.04 $347,300 - $468,704
15,100 Added 629.17%
17,500 $443,000
Q1 2024

May 14, 2024

BUY
$27.35 - $40.45 $65,640 - $97,080
2,400 New
2,400 $74,000
Q3 2023

Nov 13, 2023

BUY
$16.89 - $35.01 $1.44 Million - $2.98 Million
85,000 New
85,000 $2.24 Million
Q1 2021

May 14, 2021

SELL
$55.47 - $72.35 $715,563 - $933,314
-12,900 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$38.38 - $71.11 $495,102 - $917,319
12,900 New
12,900 $917,000

Others Institutions Holding BBIO

About BridgeBio Pharma, Inc.


  • Ticker BBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 148,246,000
  • Market Cap $3.47B
  • Description
  • BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...
More about BBIO
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.